Manuscripts
Showing 1533 manuscripts.
Addition of extended zidovudine to extended nevirapine prophylaxis reduces nevirapine resistance in infants who were HIV infected in utero
Citation
Addition of extended zidovudine to extended nevirapine prophylaxis reduces nevirapine resistance in infants who were HIV infected in utero. AIDS. 2010. 24: 381-386. PMID: 19996936Year
2010
Journal
AIDS
Pharmacokinetics of artemether-lumefantrine and artesunate-amodiaquine in children in Kampala, Uganda
Citation
Pharmacokinetics of artemether-lumefantrine and artesunate-amodiaquine in children in Kampala, Uganda. Antimicrobial Agents and Chemotherapy. 2010. 54: 52-9. PMID: 19841149Year
2010
Journal
Antimicrobial Agents and Chemotherapy
Antiretroviral treatment for children with peripartum nevirapine exposure
Citation
Michael D Hughes, Avy Violari, Mark F Cotton, Raziya Bobat, Tammy Meyers, Mutsawashe Bwakura-Dangarembizi, Benjamin H Chi, Philippa Musoke, Portia Kamthunzi, Werner Schimana, Lynette Purdue, Susan H Eshleman, Elaine J Abrams, Linda Millar, Elizabeth Petzold, Paul Palumbo, Lynne M Mofenson, Jane C Lindsey, Patrick Jean-Philippe. Antiretroviral treatment for children with peripartum nevirapine exposure. New England Journal of Medicine. 2010. 363: 1510-1520. PMID: 20942667Year
2010
Journal
New England Journal of Medicine
Study
P1060
CYP2C19 genetic variants affect nelfinavir pharmacokinetics and virologic response in HIV-1-infected children receiving highly active antiretroviral therapy
Citation
CYP2C19 genetic variants affect nelfinavir pharmacokinetics and virologic response in HIV-1-infected children receiving highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes. 2010. 54: 285-9. PMID: 19890215Year
2010
Journal
Journal of Acquired Immune Deficiency Syndromes
Analysis of drug resistance in children receiving antiretroviral therapy for treatment of HIV-1 infection in Uganda
Citation
Analysis of drug resistance in children receiving antiretroviral therapy for treatment of HIV-1 infection in Uganda. AIDS Research and Human Retroviruses. 2010. 26: 563-568. PMID: 20455758Year
2010
Journal
AIDS Research and Human Retroviruses
Analysis of HIV diversity using a high-resolution melting assay
Citation
Analysis of HIV diversity using a high-resolution melting assay. AIDS Research and Human Retroviruses. 2010. 26: 913-8. PMID: 20666583Year
2010
Journal
AIDS Research and Human Retroviruses
Clinical evaluation of a dried blood spot assay for atazanavir
Citation
Clinical evaluation of a dried blood spot assay for atazanavir. Antimicrobial Agents and Chemotherapy. 2010. 54: 4124-8. PMID: 20660680Year
2010
Journal
Antimicrobial Agents and Chemotherapy
Optimization of storage and shipment of cryopreserved peripheral blood mononuclear cells from HIV-infected and uninfected individuals for ELISPOT assays
Citation
Optimization of storage and shipment of cryopreserved peripheral blood mononuclear cells from HIV-infected and uninfected individuals for ELISPOT assays. Journal of Immunological Methods. 2010. 363: 42-50. PMID: 20888337Year
2010
Journal
Journal of Immunological Methods
Differential induction of interleukin-10 in monocytes by HIV-1 clade B and clade C Tat proteins
Citation
Differential induction of interleukin-10 in monocytes by HIV-1 clade B and clade C Tat proteins. Journal of Biological Chemistry. 2010. 285: 18319-25. PMID: 20378550Year
2010
Journal
Journal of Biological Chemistry
Emergence and persistence of nevirapine resistance in breast milk after single-dose nevirapine administration
Citation
Emergence and persistence of nevirapine resistance in breast milk after single-dose nevirapine administration. AIDS. 2010. 24: 557-61. PMID: 20057308Year
2010
Journal
AIDS